#Business #WallStreet
Positive study results for Eisai-Biogen lifted the prospects for its medication and one from Eli Lilly—although regulators will have to weigh risks.
WSJ.com: US Business
PAID
This is a business article located in the U.S. Business section of the Wall Street Journal. For the latest articles on U.S. business, current markets and other business related news follow our Twitter Page or bookmark this website.
